Neuroprotective effect of cocaine- and amphetamine-regulated transcript peptide in spinal cord injury in mice

Ashish P. Bharne, Manoj A. Upadhya, Gajanan P. Shelkar, Praful S. Singru, Nishikant K. Subhedar, Dadasaheb M. Kokare

Research output: Contribution to journalArticle

Abstract

We explored the effect of cocaine- and amphetamine-regulated transcript peptide (CART), alone and in combination with methylprednisolone (MP), on the cellular pathology and locomotor recovery of mice following spinal cord injury (SCI). While cellular pathology was evaluated in terms of spinal cord histology and profile of astrocytes following immunolabeling with antibodies against glial fibrillary acidic protein (GFAP), locomotor recovery was monitored using hindlimb motor function scoring system. At 24 h post-SCI, there was a massive loss of motor function and cysts formation in the spinal cord. The SCI mice, following 3 days and onwards, showed a significant (P < 0.001) increase in the population and hypertrophy of GFAP + astrocytes, suggesting the occurrence of reactive astrogliosis. Intra-fourth ventricular administration of CART (54–102) or intravenous treatment with MP, dose dependently improved motor function score, while CART-antibody (intra-fourth ventricular) was ineffective. This neuroprotective effect of MP was potentiated by the subeffective dose of CART and antagonized by CART-antibody. CART or MP treatment not only prevented the cysts formation, but also significantly attenuated the population of GFAP + astrocytes at days 3, 7, 14, 21 and 28 post-SCI and the hypertrophy of astrocytes at day 14 and 28. The histological consequence of SCI, like cysts formation in the spinal cord, was rapidly improved by CART and/or MP. Taken together, the data suggest that CART may exert its neuroprotective effect via inhibition of post-SCI astrogliosis and participate in the MP mediated neuroprotection.
Original languageEnglish
Pages (from-to)126-135
JournalNeuropharmacology
Volume67
DOIs
Publication statusPublished - 1 Apr 2013

Fingerprint

Neuroprotective Agents
Amphetamine
Spinal Cord Injuries
Cocaine
Methylprednisolone
Peptides
Astrocytes
Glial Fibrillary Acidic Protein
Cysts
Spinal Cord
Hypertrophy
Antibodies
Pathology
Hindlimb
Population
Histology
Therapeutics

Cite this

Bharne, Ashish P. ; Upadhya, Manoj A. ; Shelkar, Gajanan P. ; Singru, Praful S. ; Subhedar, Nishikant K. ; Kokare, Dadasaheb M. / Neuroprotective effect of cocaine- and amphetamine-regulated transcript peptide in spinal cord injury in mice. In: Neuropharmacology. 2013 ; Vol. 67. pp. 126-135.
@article{b7fbc0002d274d45beef464ea87e270f,
title = "Neuroprotective effect of cocaine- and amphetamine-regulated transcript peptide in spinal cord injury in mice",
abstract = "We explored the effect of cocaine- and amphetamine-regulated transcript peptide (CART), alone and in combination with methylprednisolone (MP), on the cellular pathology and locomotor recovery of mice following spinal cord injury (SCI). While cellular pathology was evaluated in terms of spinal cord histology and profile of astrocytes following immunolabeling with antibodies against glial fibrillary acidic protein (GFAP), locomotor recovery was monitored using hindlimb motor function scoring system. At 24 h post-SCI, there was a massive loss of motor function and cysts formation in the spinal cord. The SCI mice, following 3 days and onwards, showed a significant (P < 0.001) increase in the population and hypertrophy of GFAP + astrocytes, suggesting the occurrence of reactive astrogliosis. Intra-fourth ventricular administration of CART (54–102) or intravenous treatment with MP, dose dependently improved motor function score, while CART-antibody (intra-fourth ventricular) was ineffective. This neuroprotective effect of MP was potentiated by the subeffective dose of CART and antagonized by CART-antibody. CART or MP treatment not only prevented the cysts formation, but also significantly attenuated the population of GFAP + astrocytes at days 3, 7, 14, 21 and 28 post-SCI and the hypertrophy of astrocytes at day 14 and 28. The histological consequence of SCI, like cysts formation in the spinal cord, was rapidly improved by CART and/or MP. Taken together, the data suggest that CART may exert its neuroprotective effect via inhibition of post-SCI astrogliosis and participate in the MP mediated neuroprotection.",
author = "Bharne, {Ashish P.} and Upadhya, {Manoj A.} and Shelkar, {Gajanan P.} and Singru, {Praful S.} and Subhedar, {Nishikant K.} and Kokare, {Dadasaheb M.}",
year = "2013",
month = "4",
day = "1",
doi = "10.1016/j.neuropharm.2012.10.028",
language = "English",
volume = "67",
pages = "126--135",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier",

}

Neuroprotective effect of cocaine- and amphetamine-regulated transcript peptide in spinal cord injury in mice. / Bharne, Ashish P.; Upadhya, Manoj A.; Shelkar, Gajanan P.; Singru, Praful S.; Subhedar, Nishikant K.; Kokare, Dadasaheb M.

In: Neuropharmacology, Vol. 67, 01.04.2013, p. 126-135.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Neuroprotective effect of cocaine- and amphetamine-regulated transcript peptide in spinal cord injury in mice

AU - Bharne, Ashish P.

AU - Upadhya, Manoj A.

AU - Shelkar, Gajanan P.

AU - Singru, Praful S.

AU - Subhedar, Nishikant K.

AU - Kokare, Dadasaheb M.

PY - 2013/4/1

Y1 - 2013/4/1

N2 - We explored the effect of cocaine- and amphetamine-regulated transcript peptide (CART), alone and in combination with methylprednisolone (MP), on the cellular pathology and locomotor recovery of mice following spinal cord injury (SCI). While cellular pathology was evaluated in terms of spinal cord histology and profile of astrocytes following immunolabeling with antibodies against glial fibrillary acidic protein (GFAP), locomotor recovery was monitored using hindlimb motor function scoring system. At 24 h post-SCI, there was a massive loss of motor function and cysts formation in the spinal cord. The SCI mice, following 3 days and onwards, showed a significant (P < 0.001) increase in the population and hypertrophy of GFAP + astrocytes, suggesting the occurrence of reactive astrogliosis. Intra-fourth ventricular administration of CART (54–102) or intravenous treatment with MP, dose dependently improved motor function score, while CART-antibody (intra-fourth ventricular) was ineffective. This neuroprotective effect of MP was potentiated by the subeffective dose of CART and antagonized by CART-antibody. CART or MP treatment not only prevented the cysts formation, but also significantly attenuated the population of GFAP + astrocytes at days 3, 7, 14, 21 and 28 post-SCI and the hypertrophy of astrocytes at day 14 and 28. The histological consequence of SCI, like cysts formation in the spinal cord, was rapidly improved by CART and/or MP. Taken together, the data suggest that CART may exert its neuroprotective effect via inhibition of post-SCI astrogliosis and participate in the MP mediated neuroprotection.

AB - We explored the effect of cocaine- and amphetamine-regulated transcript peptide (CART), alone and in combination with methylprednisolone (MP), on the cellular pathology and locomotor recovery of mice following spinal cord injury (SCI). While cellular pathology was evaluated in terms of spinal cord histology and profile of astrocytes following immunolabeling with antibodies against glial fibrillary acidic protein (GFAP), locomotor recovery was monitored using hindlimb motor function scoring system. At 24 h post-SCI, there was a massive loss of motor function and cysts formation in the spinal cord. The SCI mice, following 3 days and onwards, showed a significant (P < 0.001) increase in the population and hypertrophy of GFAP + astrocytes, suggesting the occurrence of reactive astrogliosis. Intra-fourth ventricular administration of CART (54–102) or intravenous treatment with MP, dose dependently improved motor function score, while CART-antibody (intra-fourth ventricular) was ineffective. This neuroprotective effect of MP was potentiated by the subeffective dose of CART and antagonized by CART-antibody. CART or MP treatment not only prevented the cysts formation, but also significantly attenuated the population of GFAP + astrocytes at days 3, 7, 14, 21 and 28 post-SCI and the hypertrophy of astrocytes at day 14 and 28. The histological consequence of SCI, like cysts formation in the spinal cord, was rapidly improved by CART and/or MP. Taken together, the data suggest that CART may exert its neuroprotective effect via inhibition of post-SCI astrogliosis and participate in the MP mediated neuroprotection.

UR - https://linkinghub.elsevier.com/retrieve/pii/S002839081200531X

U2 - 10.1016/j.neuropharm.2012.10.028

DO - 10.1016/j.neuropharm.2012.10.028

M3 - Article

VL - 67

SP - 126

EP - 135

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

ER -